Transcription of Sotrovimab Product Monograph
{{id}} {{{paragraph}}}
Example: air traffic controller
Sotrovimab Product Monograph
SotrovimabProduct MonographPage 1 of 24 Product MONOGRAPHINCLUDING PATIENT MEDICATION INFORMATIONPrSotrovimabfor injectionSolution for infusion, 500 mg/8 mL ( mg/mL)single use vialATC Classification: Specific Immunoglobulin( anti -SARS-CoV-2 spike protein monoclonal antibody )HEALTH CANADA HAS AUTHORIZED THE SALE OF THIS COVID-19 DRUG BASED ON LIMITED CLINICAL TESTING IN HUMANS AND/OR QUALITY INFORMATIONS otrovimabis indicated forthe treatment of mild to moderate coronavirus disease 2019 (COVID-19), confirmed by direct SARS-CoV-2 viral testing, in adults and adolescents (12 years of age and older weighing at least 40kg)
(Anti-SARS-CoV-2 spike protein monoclonal antibody) HEALTH CANADA HAS AUTHORIZED THE SALE OF THIS COVID-19 DRUG BASED ON LIMITED CLINICAL TESTING IN HUMANS AND/OR QUALITY INFORMATION Sotrovimabis indicated forthe treatment of mild to moderate coronavirus disease 2019 (COVID-19),
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: